Triptorelin is a gonadotropin-releasing hormone analogue; in 66 children treated with slow-release triptorelin for central precocious puberty, final height matched the genetic target, and girls gained 4.8 cm over their predicted height.
established — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
emerging
Claim: Final height after long-term triptorelin for central precocious pubertystanding
resolved
Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL
Claim: Triptorelin during chemotherapy and early menopause in breast cancer (phase 3 RCT)standing
resolved
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M
A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.